Please login to the form below

Not currently logged in
Email:
Password:

company restructuring

This page shows the latest company restructuring news and features for those working in and with pharma, biotech and healthcare.

Boehringer starts to feel impact of Spiriva generics

Boehringer starts to feel impact of Spiriva generics

To that end, Boehringer is in the throes of a major restructuring of its businesses. ... Boehringer has also embarked on a restructuring of its human pharmaceuticals and innovation corporate board divisions, eliminating around 725 jobs in the US.

Latest news

  • Astellas sells dermatology unit to Leo for €675m Astellas sells dermatology unit to Leo for €675m

    Continuesthe company's restructuring drive. Japan's Astellas has continued the restructuring of its business started in 2013 with the sale of its dermatology operations to Danish firm Leo Pharma. . ... There have been rumours of a sale of the unit since

  • Healthcare gets more independence in Google restructuring Healthcare gets more independence in Google restructuring

    New ‘Alphabet’ company will put tech giant’s health ventures centre-stage.  . Google is re-organising to create a leaner organisation, and its healthcare operations have a central place in the ... the Internet arm, which generates most of the

  • GSK hints at more restructuring following income drop GSK hints at more restructuring following income drop

    GlaxoSmithKline (GSK) has hinted at additional asset disposals and restructuring as it reported drops in both sales and earnings in the fourth quarter. ... The key for the company in 2015 will be to “deliver on the cost-cutting programme, the pipeline

  • Shire to file Vyvanse for binge-eating in Q3 Shire to file Vyvanse for binge-eating in Q3

    This is a condition with few patient treatment options available, "said Shire's chief executive Flemming Ornskov, who has implemented a major restructuring drive at the company - including a concerted push ... Meanwhile, Shire also announced that chief

  • New York plant set to close as Novartis continues cutbacks New York plant set to close as Novartis continues cutbacks

    Last November, Novartis chief financial officer Harry Kirsch gave an update on the company's manufacturing restructuring programme, indicating that it has exited or divested 18 of more than 100 sites ... Since then, the company has also announced it

More from news
Approximately 1 fully matching, plus 30 partially matching documents found.

Latest Intelligence

  • Pharma deals during September 2014 Pharma deals during September 2014

    Company restructuring and portfolio rationalisation. Following restructuring by Pfizer, GSK, Novartis, Lilly and Merck &Co, Bayer has jumped on the portfolio rationalisation bandwagon with its decision to spin off as a ... separate listed company its

  • Sandra Rafferty: 'If I could change one thing…' Sandra Rafferty: 'If I could change one thing…'

    I met a friend recently who has been a sales rep for a number of years and she told me her company had been through a restructuring process to adopt the ... It is only when the perception of KAM is changed and a KAM approach is adopted fully across the

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Sue Mahony to retire as president of Lilly Oncology Sue Mahony to retire as president of Lilly Oncology

    She also most recently led the refocusing of the company’s oncology R&D strategy. ... Prior to this, as senior vice president of human resources and diversity, Mahony played in a role in restructuring the company into business units.

  • AZ names Dunoyer as CFO AZ names Dunoyer as CFO

    He succeeds Simon Lowth as company restructure continues apace. AstraZeneca (AZ) has announced that Marc Dunoyer will take over from Simon Lowth as the company's chief financial officer. ... Group. Dunoyer only joined AZ in June this year as executive VP,

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics